OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+35.52%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$376M
AUM Growth
+$376M
(+22%)
Cap. Flow
+$4M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
62.6%
Holding
53
New
13
Increased
11
Reduced
14
Closed
8
Top Buys
| 1 |
Arvinas
ARVN
|
$10.9M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$6.33M |
| 3 |
Codexis
CDXS
|
$5.88M |
| 4 |
TG Therapeutics
TGTX
|
$5.55M |
| 5 |
Relmada Therapeutics
RLMD
|
$3.51M |
Top Sells
| 1 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$10.5M |
| 2 |
Biohaven
BHVN
|
$10.2M |
| 3 |
TELA Bio
TELA
|
$6M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$4.29M |
| 5 |
Geron
GERN
|
$4.06M |
Sector Composition
| 1 | Healthcare | 97.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Geron
GERN
$893M
| – | – |
-1,915,000
| Closed | -$4.06M |
|
52
Fortress Biotech
FBIO
$87.8M
| – | – |
-2,000,000
| Closed | -$581K |
|